Sign in
CompletedNo phase

CEUS For Intraoperative Spinal Cord Injury

Key facts

Who runs it
Medical University of South Carolina
Where
Charleston, United StatesSee the site
Trial code
Status
Completed
People taking part
20 people enrolled
Started
1 Dec 2023
Ended
1 Aug 2025
Type of study
Interventional
Treatments tested
  • Definity Perflutren Lipid Microsphere Ultrasound Contrast
Record updated
15 October 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Patients consented and scheduled for posterior cervicothoracic decompression surgery with the PI for the diagnosis of cervicothoracic myeloradiculopathy
  • Age 18-80

Who cannot take part

  • Prior decompression at the intended level of decompression
  • Patient's with known hypersensitivity to ultrasound contrast
  • Patients with known hypersensitivity to perflutren lipid microsphere or its components, such as polyethylene glycol (PEG)
  • Pregnancy
  • Patients unable to actively participate in the consent process physically and/or cognitively

Where in United States

  • Medical University of South CarolinaCharleston, United States

About the trial

What the trial wants to find out

Spinal cord injury following posterior decompression in patients suffering from chronic, cervicothoracic spinal cord compression is a known complication with multiple etiologies. Currently, intraoperative neuromonitoring (IONM) remains the gold standard for predicting and preventing post-operative deficits from these procedures. However, there is a paucity in the field of spine surgery for further, non-invasive biomarkers that can help detect and prognosticate the degree of spinal cord injury intraoperatively. Contrast enhanced ultrasound (CEUS) is a radiation free imaging modality that utilizes nanobubble technology to allow for visualization of the macro- and microvascular architecture of soft tissue structures. Despite being currently approved for the use in hepatology and cardiology, it has remained absent from the field of spinal cord injury. The study team aims to evaluate and quantify micro- and macrovascular changes that lead to areas of hyper-perfusion as well as areas of ischemia intraoperatively in patients that undergo elective cervicothoracic posterior decompression for chronic compression. In addition, the study team aims to assess the efficacy of CEUS in detecting microvascular changes that correlate with IONM changes and predicting degree and recovery of post-operative neurologic deficits from intraoperative spinal cord injury. The study team hypothesizes that following decompression, subjects will have detectable levels of microvascular changes causing areas of hypoperfusion and reperfusion injury. Second, the study team hypothesizes that these perfusion changes will correlate with intraoperative neuromonitoring changes and can predict and prognosticate the degree of post-operative neurologic injury.

The group in the trial

  • Contrast Enhanced Ultrasound ArmTreatment being tested

    Treatment: Definity Perflutren Lipid Microsphere Ultrasound Contrast

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Contrast Enhanced Ultrasound for The Evaluation of Intraoperative Spinal Cord Injury Following Surgical Decompression of a Chronically Compressed Spinal Cord
Record updated
15 October 2026